CONCIEO PHARMA, LLC Trademark

Trademark Overview


On Thursday, October 28, 2021, a trademark application was filed for CONCIEO PHARMA, LLC with the United States Patent and Trademark Office. The USPTO has given the CONCIEO PHARMA, LLC trademark a serial number of 97098251. The federal status of this trademark filing is REGISTERED as of Tuesday, August 15, 2023. This trademark is owned by Concieo Pharma, LLC. The CONCIEO PHARMA, LLC trademark is filed in the Chemical Products, Pharmaceutical Products, and Treatment & Processing of Materials Services categories with the following description:

Custom manufacture of active pharmaceutical ingredients, chemical compounds, and biologicals for pharmaceutical preparations

Pharmaceutical preparations for the treatment of cancer, infectious diseases, autoimmune disorders, cardiovascular diseases, blood disorders, neurologic disorders, skin diseases, musculoskeletal disorders, genetic disorders, digestive disorders, diabetes-related conditions, eye conditions, viral, and transplants

Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, infectious diseases, autoimmune disorders, cardiovascular diseases, blood disorders, neurologic disorders, skin diseases, musculoskeletal disorders, genetic disorders, digestive disorders, diabetes-related conditions, eye conditions, viral, and transplants
concieo pharma, llc

General Information


Serial Number97098251
Word MarkCONCIEO PHARMA, LLC
Filing DateThursday, October 28, 2021
Status700 - REGISTERED
Status DateTuesday, August 15, 2023
Registration Number7140342
Registration DateTuesday, August 15, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2022

Trademark Statements


Goods and ServicesCustom manufacture of active pharmaceutical ingredients, chemical compounds, and biologicals for pharmaceutical preparations
Goods and ServicesPharmaceutical preparations for the treatment of cancer, infectious diseases, autoimmune disorders, cardiovascular diseases, blood disorders, neurologic disorders, skin diseases, musculoskeletal disorders, genetic disorders, digestive disorders, diabetes-related conditions, eye conditions, viral, and transplants
Goods and ServicesActive chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, infectious diseases, autoimmune disorders, cardiovascular diseases, blood disorders, neurologic disorders, skin diseases, musculoskeletal disorders, genetic disorders, digestive disorders, diabetes-related conditions, eye conditions, viral, and transplants
Disclaimer with Predetermined Text"PHARMA, LLC"

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, November 10, 2021
Primary Code001
First Use Anywhere DateTuesday, April 11, 2023
First Use In Commerce DateTuesday, April 11, 2023

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 10, 2021
Primary Code005
First Use Anywhere DateTuesday, April 11, 2023
First Use In Commerce DateTuesday, April 11, 2023

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, November 10, 2021
Primary Code040
First Use Anywhere DateTuesday, April 11, 2023
First Use In Commerce DateTuesday, April 11, 2023

Trademark Owner History


Party NameConcieo Pharma, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressMemphis, TN 38104

Party NameConcieo Pharma, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMemphis, TN 38104

Party NameConcieo Pharma, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMemphis, TN 38104

Trademark Events


Event DateEvent Description
Tuesday, August 15, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 15, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, July 12, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 11, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 11, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, July 11, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 11, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, July 11, 2023SU-EXAMINER'S AMENDMENT WRITTEN
Monday, June 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 12, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 12, 2023NON-FINAL ACTION E-MAILED
Monday, June 12, 2023SU - NON-FINAL ACTION - WRITTEN
Wednesday, May 17, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, April 27, 2023USE AMENDMENT FILED
Wednesday, May 17, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 27, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, November 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 24, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 10, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, August 10, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 10, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, August 10, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, August 5, 2022ASSIGNED TO EXAMINER
Wednesday, November 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 1, 2021NEW APPLICATION ENTERED